SARAH HOLY, MD
Retina Specialist (Ophthalmology) Physician · SAN ANTONIO, TX
Individual Active NPI 1275514796
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,357 | 48,098 | $18,052,496 | $5,518,027 | $4,354,860 |
| 2023 | 1,275 | 33,424 | $14,256,084 | $4,508,211 | $3,555,276 |
| 2022 | 1,274 | 16,442 | $8,201,877 | $4,056,146 | $3,197,570 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 32,342 | $34 | $27 |
| J0177 | Injection, aflibercept hd, 1 mg | 3,952 | $329 | $262 |
| 92134 | Imaging of retina | 3,099 | $40 | $30 |
| 67028 | Injection of drug into eye | 2,001 | $129 | $98 |
| J0178 | Injection, aflibercept, 1 mg | 1,952 | $820 | $652 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,403 | $227 | $180 |
| 92014 | Established patient complete exam of visual system | 1,332 | $126 | $90 |
| J2778 | Injection, ranibizumab, 0.1 mg | 351 | $158 | $126 |
| 92250 | Photography of the retina | 242 | $37 | $29 |
| 92004 | New patient complete exam of visual system | 176 | $147 | $105 |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 175 | $167 | $133 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 146 | $25 | $19 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | ✓ | M1150 | TX |
Medicare eligibility
- Part B
- No
- DME
- Yes
- Home health
- No
- Power mobility
- Yes
- Hospice
- No
Other Retina Specialist (Ophthalmology) Physician providers in Texas
- NPI 1083871818
- NPI 1740031624
- NPI 1669850335
- NPI 1306348032
- NPI 1457512725
- NPI 1114791035
- NPI 1285878983
- NPI 1578068623
See all Retina Specialist (Ophthalmology) Physician providers in Texas →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.